The Arachnoid Cysts Market Size was valued at USD 1.20 Billion in 2023. The Global Arachnoid Cysts industry is projected to grow from USD 2.09 Billion in 2024 to USD 4.60 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.76% during the forecast period (2024 - 2032). Arachnoid cysts are a type of brain cyst cause between the split of the arachnoid membrane, which is one of the 3 layers of the tissue that covers the brain and the spinal cord.
Rising number of patients suffering from meningitis, tumors and head injuries are expected to drive the growth of the market. According to a report published by the American Society of Clinical Oncology in November 2017, an estimated 23,880 people are expected to be diagnosed with brain and spinal cord tumors in 2017. Moreover, favorable healthcare expenditures boost the growth of the market. However, lack of knowledge may hamper the market growth during the assessment period.
The arachnoid cysts market has been segmented into type, diagnosis, and treatment.
The market, on the basis of type, has been segmented into, intracranial and spinal. Intracranial arachnoid cysts are expected to hold the largest market share because of high incidences of the type. Spinal arachnoid cysts are expected to grow at the fastest CAGR owing to rising cases of spinal injuries resulting in cysts.
The market, by diagnosis, has been segmented into, CT scan, MRI scan, prenatal ultrasound, and other tests.
The market, by treatment, has been segmented into, permanent drainage system surgery, fenestration, and endoscopic cyst fenestration.
The market, by region, has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The arachnoid cysts market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European arachnoid cysts market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The arachnoid cysts market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The arachnoid cysts market in the Middle East & Africa has been segmented into the Middle East and Africa.
Geographically, the Americas is anticipated to dominate the arachnoid cysts market owing to technological advancements and rising prevalence of tumor & meningitis. According to a report published by American Society of Clinical Oncology in November 2017, about 3,560 children are expected to be diagnosed with a brain tumor or CNS tumor in 2017.
Europe is expected to hold the second largest position in the arachnoid cysts market. The market growth in this region is attributed to the growing prevalence of spinal cord & brain tumors and increasing healthcare expenditure. According to Cancer Research UK, 11,432 new cases of brain tumors were reported in 2015 in the UK.
Asia-Pacific is anticipated to be the fastest growing region in the market due to the rising awareness of tumors & meningitis and government support for healthcare facilities. According to a study published by the European Society for Medical Oncology in January 2016, there were 4.3 million new cases of cancer in China in 2015.
On the other hand, the Middle East & Africa has the least market share. Majority of the market of this region is expected to be held by the Middle East region due to growing government initiatives for the improvement of the healthcare sector.
Key players
Some of the key players in the arachnoid cysts market are
Intended Audience
| Report Attribute/Metric | Details |
| Â Â Market Size 2032 | Â USD 4.60 Billion |
| Â Â CAGR | 8.76% (2024-2032) |
| Â Â Base Year | 2023 |
| Â Â Forecast Period | 2024-2032 |
| Â Â Historical Data | 2021 |
| Â Â Forecast Units | Value (USD Billion) |
| Â Â Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Â Â Segments Covered | Type, Diagnosis, and Treatment |
| Â Â Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Â Â Key Vendors | Spiegelberg GmbH & Co. KG ., Sophysa, Aesculap, Inc., DePuy Synthes, Medtronic, Integra LifeSciences, Christoph Miethke GmbH & Co. KG, Tokibo Co. Ltd., Boston Neurosciences, Koninklijke Philips N.V., GENERAL ELECTRIC COMPANY, Hitachi Medical Systems Europe, Siemens Healthcare Private Limited and FUJIFILM SonoSite, Inc. |
| Â Â Key Market Opportunities | Rising number of patients suffering from meningitis, tumors and head injuries |
| Â Â Key Market Drivers | Favorable healthcare expenditures |
Frequently Asked Questions (FAQ) :
Lack of knowledge may hamper the arachnoid cysts market.
The diagnosis part of arachnoid cysts market has CT scan, MRI scan, prenatal ultrasound, and other tests.
The Americas would top the arachnoid cysts market.
The fastest-growing regional arachnoid cysts market would be Asia Pacific.
Arachnoid cysts market in Europe would benefit from increasing spinal cord and brain tumor studies, along with high healthcare expenditures.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
